{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:43:04Z","timestamp":1780432984190,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cyto.2023.156385","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T20:47:31Z","timestamp":1696193251000},"page":"156385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Aberrant cytokine and VCAM-1 expression in patients with viral and non-viral related liver cirrhosis"],"prefix":"10.1016","volume":"171","author":[{"given":"Sara A.","family":"El-Mokhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha A.","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed O.","family":"Abdel-Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helal","family":"Hetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8445-711X","authenticated-orcid":false,"given":"Omnia","family":"El-Badawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bpg.2011.02.009","article-title":"Liver cirrhosis","volume":"25","author":"Pinzani","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.cyto.2023.156385_b0010","unstructured":"W.H. Organization, Global health estimates: leading causes of death, cause-specific mortality, 2000\u20132019, 2023."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5152\/eajm.2014.25","article-title":"The frequency of complications and the etiology of disease in patients with liver cirrhosis in erzurum","volume":"46","author":"Topdagi","year":"2014","journal-title":"The Eurasian Journal of Medicine"},{"key":"10.1016\/j.cyto.2023.156385_b0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fimmu.2019.00452","article-title":"Contribution of cytokines to tissue damage during human respiratory syncytial virus infection","volume":"10","author":"Bohmwald","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/v9010018","article-title":"Control of hepatitis B virus by cytokines","volume":"9","author":"Xia","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/cancers6010079","article-title":"The complex relationship between liver cancer and the cell cycle: a story of multiple regulations","volume":"6","author":"Bisteau","year":"2014","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.cyto.2023.156385_b0035","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1053\/j.gastro.2015.08.053","article-title":"CSF1 restores innate immunity after liver injury in mice and serum levels indicate outcomes of patients with acute liver failure","volume":"149","author":"Stutchfield","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cyto.2023.156385_b0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/brainsci8060101","article-title":"Anti-cytokine therapy to attenuate ischemic-reperfusion associated brain injury in the perinatal period","volume":"8","author":"Disdier","year":"2018","journal-title":"Brain Sci."},{"issue":"29","key":"10.1016\/j.cyto.2023.156385_b0045","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.3748\/wjg.v11.i29.4566","article-title":"Circulating adhesion molecules in patients with virus-related chronic diseases of the liver","volume":"11","author":"Bruno","year":"2005","journal-title":"World J Gastroenterol: WJG"},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-11975-7","article-title":"Differential serum cytokine profiles in patients with chronic hepatitis b, c, and hepatocellular carcinoma","volume":"7","author":"Estevez","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cyto.2023.156385_b0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"International Autoimmune Hepatitis, Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cyto.2023.156385_b0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"J Methods"},{"issue":"8","key":"10.1016\/j.cyto.2023.156385_b0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2893.2006.00834.x","article-title":"Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection","volume":"14","author":"Pham","year":"2007","journal-title":"J. Viral Hepat."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1189\/jlb.2A1211-608RRRR","article-title":"Hepatitis C virus (HCV)-induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF-alpha responses","volume":"96","author":"Collins","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2008-12-191296","article-title":"IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells","volume":"114","author":"Brockman","year":"2009","journal-title":"J Blood"},{"issue":"11","key":"10.1016\/j.cyto.2023.156385_b0085","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.imbio.2014.07.009","article-title":"Vitamin D reduces the differentiation and expansion of Th17 cells in young asthmatic children","volume":"219","author":"Hamzaoui","year":"2014","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.cyto.2023.156385_b0090","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.174.3.1647","article-title":"Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-kappa B-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression","volume":"174","author":"Yang","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2023.156385_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/345803","article-title":"Role of IL-17 and Th17 cells in liver diseases","volume":"2011","author":"Hammerich","year":"2011","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-008-8091-0","article-title":"Inflammatory pathways in liver homeostasis and liver injury","volume":"36","author":"Tacke","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2014.10.009","article-title":"An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17","volume":"26","author":"Grine","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.cyto.2023.156385_b0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2893.2011.01561.x","article-title":"Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis","volume":"19","author":"Sun","year":"2012","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.cyto.2023.156385_b0115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cyto.2023.156385_b0120","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1440-1746.2011.06782.x","article-title":"Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C","volume":"27","author":"Chang","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156385_b0130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1600-6143.2011.03458.x","article-title":"Characterization of HCV-Specific CD4+ Th17 Immunity in Recurrent Hepatitis C-Induced Liver Allograft Fibrosis","volume":"11","author":"Basha","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10875-009-9328-2","article-title":"Implication of Th17 and Th1 cells in patients with chronic active hepatitis B","volume":"30","author":"Ge","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2023.156385_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2012.12.001","article-title":"Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection","volume":"149","author":"Yang","year":"2013","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.15171\/mejdd.2018.134","article-title":"Enhanced Th17 Responses in Patients with Autoimmune Hepatitis","volume":"11","author":"Behfarjam","year":"2019","journal-title":"Middle East J. Dig. Dis"},{"issue":"4","key":"10.1016\/j.cyto.2023.156385_b0150","doi-asserted-by":"crossref","first-page":"e18909","DOI":"10.1371\/journal.pone.0018909","article-title":"Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cyto.2023.156385_b0155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1034\/j.1600-6143.2003.00124.x","article-title":"Regulatory T cells in the control of transplantation tolerance and autoimmunity","volume":"3","author":"Jiang","year":"2003","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.cyto.2023.156385_b0160","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1515\/BC.2009.111","article-title":"Mechanisms of liver disease: cross-talk between the NF-\u03baB and JNK pathways","volume":"390","author":"Papa","year":"2009","journal-title":"Biol. Chem."},{"issue":"4","key":"10.1016\/j.cyto.2023.156385_b0165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/er.2006-0031","article-title":"Hepatic tumor necrosis factor signaling and nuclear factor-\u03baB: effects on liver homeostasis and beyond","volume":"28","author":"Wullaert","year":"2007","journal-title":"Endocr. Rev."},{"issue":"20","key":"10.1016\/j.cyto.2023.156385_b0170","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cyto.2023.156385_b0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1020600230977","article-title":"Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease","volume":"22","author":"Ludwiczek","year":"2002","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4236\/ss.2011.22015","article-title":"Changes of IL-1, TNF-Alpha, IL-12 and IL-10 levels with chronic liver failure","volume":"2","author":"Liu","year":"2011","journal-title":"Surg. Sci."},{"issue":"8","key":"10.1016\/j.cyto.2023.156385_b0185","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/ijms19082199","article-title":"Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-\u03b1 on the liver","volume":"19","author":"Lopetuso","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0190","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1746.2002.02672.x","article-title":"Tumor necrosis factor-\u03b1 and transforming growth factor-\u03b2 reflect severity of liver damage in primary biliary cirrhosis","volume":"17","author":"Neuman","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3\u20134","key":"10.1016\/j.cyto.2023.156385_b0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.09.010","article-title":"Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis","volume":"33","author":"Barak","year":"2009","journal-title":"J. Autoimmun."},{"issue":"19","key":"10.1016\/j.cyto.2023.156385_b0200","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.3748\/wjg.v13.i19.2693","article-title":"Budd-Chiari syndrome: etiology, pathogenesis and diagnosis","volume":"13","author":"Aydinli","year":"2007","journal-title":"World J Gastroenterol: WJG"},{"issue":"12","key":"10.1016\/j.cyto.2023.156385_b0205","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1136\/gut.2005.065144","article-title":"Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease","volume":"54","author":"Paradis","year":"2005","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cyto.2023.156385_b0210","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/annrheumdis-2012-201887","article-title":"Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-\u03b1 on endothelial cells","volume":"72","author":"Hot","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2023.156385_b0215","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","article-title":"Combination of IL-17 and TNF\u03b1 induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells","volume":"71","author":"Hot","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.cyto.2023.156385_b0220","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/ard.2010.148031","article-title":"Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis","volume":"70","author":"Marder","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.cyto.2023.156385_b0225","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/hep.510280621","article-title":"Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice","volume":"28","author":"Louis","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cyto.2023.156385_b0230","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","article-title":"Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes","volume":"127","author":"Safadi","year":"2004","journal-title":"Gastroenterology"},{"issue":"79","key":"10.1016\/j.cyto.2023.156385_b0235","first-page":"2092","article-title":"Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis","volume":"54","author":"Zhang","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"10.1016\/j.cyto.2023.156385_b0240","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/1521-4141(200103)31:3<894::AID-IMMU894>3.0.CO;2-I","article-title":"Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection","volume":"31","author":"Prezzi","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0245","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cyto.2023.156385_b0250","doi-asserted-by":"crossref","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","article-title":"Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2006.10.028","article-title":"Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C","volume":"251","author":"Tachibana","year":"2007","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.cyto.2023.156385_b0260","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.1840180316","article-title":"Increased plasma interleukin-8 concentrations in alcoholic hepatitis","volume":"18","author":"Hill","year":"1993","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cyto.2023.156385_b0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/1996\/129325","article-title":"Serum soluble vascular-cell adhesion molecule-1 (VCAM-1) in patients with acute and chronic liver diseases","volume":"13","author":"Pirisi","year":"1996","journal-title":"Dis. Markers"},{"issue":"11","key":"10.1016\/j.cyto.2023.156385_b0270","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1365-2036.1998.00412.x","article-title":"Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha","volume":"12","author":"Iacono","year":"1998","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.cyto.2023.156385_b0275","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/00365520510011470","article-title":"Adhesion molecules as a prognostic marker of liver cirrhosis","volume":"40","author":"Giron-Gonzalez","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156385_b0280","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000028034","article-title":"Expression of VCAM-1 in lymphocytes during the process of apoptosis","volume":"66","author":"Ishiyama","year":"1998","journal-title":"Pathobiology"},{"issue":"3","key":"10.1016\/j.cyto.2023.156385_b0285","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.4049\/jimmunol.174.3.1574","article-title":"VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity","volume":"174","author":"Diaz","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156385_b0290","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000334175","article-title":"Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome","volume":"73","author":"Seow","year":"2012","journal-title":"Gynecol. Obstet. Invest."},{"issue":"4","key":"10.1016\/j.cyto.2023.156385_b0295","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00705-016-3213-0","article-title":"Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: a study of adult T cell leukemia malignancy associated with HTLV-1","volume":"162","author":"Jafarian","year":"2017","journal-title":"Arch. Virol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:08:26Z","timestamp":1736417306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623002636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":59,"alternative-id":["S1043466623002636"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156385","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant cytokine and VCAM-1 expression in patients with viral and non-viral related liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156385"}}